AMPA Receptors: A Target for Novel Antidepressants?

Biological Psychiatry

Volumn 63, Issue 4, 2008, Pages 347-348

  Skolnick, Phil ^a  

^a DOV Pharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMPA RECEPTOR AGONIST; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DIZOCILPINE; IMIPRAMINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N [2 [4 (3 THIENYL)PHENYL]PROPYL] 2 PROPANESULFONAMIDE; PHENCYCLIDINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG INFUSION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; HAMILTON SCALE; HUMAN; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

EID: 38349180147     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.10.011     Document Type: Note

References (10)

1. Zarate C., Singh J.B., Carlson P.J., Brutsche N.E., Amell R., Luckenbaugh D.A., et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment resistant depression. Arch Gen Psychiat 63 (2006) 856-964
2. Berman R.M., Cappiello A., Anand A., Oren D., Charney D.S., and Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47 (2000) 351-354
3. Paul I.A., and Skolnick P. Glutamate and depression: Clinical and preclinical studies. Ann New York Acad Sci 1003 (2003) 250-272
4. Alt A., Nisenbaum E.S., Bleakman D., and Witkin J.M. A role for AMPA receptors in mood disorders. Biochem Pharmacol 71 (2006) 1273-1288
5. Maeng S., Zarate C.A., Du J., Schloesser R.J., McCammon J., Chen G., et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63 (2008) 349-352
6. Moghaddam B., Adams B., Verma A., and Daly D. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with prefrontal cortex. J Neurosci 17 (1997) 2921-2927
7. Skolnick P., Legutko B., Li X., and Bymaster F.P. Current perspectives on the development of non-biogenic amine based antidepressants. Pharmacol Res 43 (2001) 411-423
8. Duman R. Neurotrophic factors in etiology and treatment of mood disorders. In: Sibley D., Hanin I., Kuhar M., and Skolnick P. (Eds). Handbook of Contemporary Neuropharmacology (2007), Wiley, Hoboken, NJ 789-815
9. Rantamaki T., Hendolin P., Kankaanpaa A., Mijatovic J., Piepponen P., Domenici E., et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and Induce Phospholipase-Cγ signaling pathways in mouse. Neuropsychopharmacol 32 (2007) 2152-2162
10. Li X., Witkin J.M., Need A.B., and Skolnick P. Enhancement of antidepressant potency by a potentiator of AMPA receptors. Cell Mol Neurobiol 23 (2003) 419-430